COVID-19 Offerings COVID-19 Research Use Only Offerings

COVID-19 Update

Standard BioTools Research and Response to the COVID-19 Pandemic

Standard BioTools™ supports the response to the global COVID-19 pandemic with technologies that enable research and applications for SARS-CoV-2 virus detection and the monitoring of human immune system response to infection and COVID-19 disease. To that end, our technologies are well-positioned for use in providing a robust public research response in support of policies and treatments aligned with local, state and national recovery.

Technology & Research

COVID-19 Diagnostics

The Advanta™ Dx SARS-CoV-2 RT-PCR Assay is a qPCR-based test that, by taking advantage of Standard BioTools proprietary microfluidics technology and the Juno™ and Biomark™ HD systems, enables reliable...

COVID-19 Disease Immune Monitoring and Spatial Tissue Profiling Research

Standard BioTools CyTOF® technology with the Maxpar® Direct™ Immune Profiling Assay™ provide best-in-class immune monitoring with the cost, flexibility and consistency needed for standardized COVID-1...

COVID-19 Disease Therapeutic and Vaccine Development

Both CyTOF technology with the Maxpar Direct Immune Profiling Assay and Imaging Mass Cytometry™ enable immune response studies designed to identify prognostic and mechanistic biomarkers that can be us...

SARS-CoV-2 Mutation Assay Panel

SARS-CoV-2, like all RNA viruses, evolves and mutates. Since its discovery, the viral sequence for the novel coronavirus has accumulated a staggering number of mutations, giving rise to more virulent,...

Proven performance

Maxpar Direct Immune Profiling System

Learn more about the Maxpar Direct Immune Profiling Assay and Maxpar Pathsetter™ software, the first complete sample-to-answer solution for high-dimensional immune profiling of human PBMC and whole blood, with proven performance in multi-site studies.

Read the recent paper reporting results from the Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) study, a longitudinal, multi-site study that used the Maxpar Direct Immune Profiling Assay as a key assay in its multi-omic workflow.


Learn more

background pattern

Therapeutic Insights Services in Support of Your Research

Therapeutic Insights Services offers sample-to-answer mass cytometry and Imaging Mass Cytometry services for your research needs. If expertise and capabilities are needed for your COVID-19 related research or if local facilities are affected by closures, we are ready to assist. Consultation, sample staining and data acquisition and analysis options are available. Select services offered include:

  • Custom panel design
  • Data analysis and reporting
  • Sample staining
  • Mass cytometry data acquisition and analysis
  • Imaging Mass Cytometry data acquisition, processing and analysis

Learn more or contact us at tis@fluidigm.com.

Events & Webinars

Standard BioTools Infectious Disease and Oncology Virtual Summit


We invite you to join us for a half-day virtual event where researchers will share their latest findings in infectious disease, oncology or immuno-oncology research. Speakers will include Burkhard Becher, PhD, Evan Newell, PhD, Hiroyoshi Nishikawa, MD, PhD, and Kurt Schalper, MD, PhD.

Don’t miss this exciting event bridging the space from technological innovations to real world applications and results that impact human health.

Watch on demand

Webinar: Bring the Power of CyTOF to COVID-19 Research

 


Presenter:
Andrew Quong, PhD
Chief Science Officer

Download Q&A

Webinar: Detection and Characterization of Viral Pathogens with Microfluidics-Based Genomic Analysis


Presenter:
Bill Hunt, MS
Director, Microfluidics Product Management

Read Q&A
All resources

Get more information

Unless explicitly and expressly stated otherwise, all products are provided for Research Use Only, not for use in diagnostic procedures. Find more information here.